Table 3.
The baseline and characteristics of patients.
| Control without glucocorticoid | Short term use of glucocorticoid | Long term use of glucocorticoid | |
|---|---|---|---|
| Number of patients | 22 | 20 | 18 |
| Time of glucocorticoid | 0 | <3 months | >3 months |
| Glucose fasting (mmol/L) | 4.9 ± 1.3 | 5.1 ± 0.7 | 5.3 ± 1.1 |
| Glucose 2 h after dinner (mmol/L) | 6.9 ± 0.7 | 7.1 ± 0.7 | 9.3 ± 2.6∗ |
| ACTH 8 am (pmol/L) | 6.5 ± 0.4 | 7.2 ± 0.7 | 7.9 ± 0.3 |
| HDL (high density lipoprotein, mmol/L) | 1.49 ± 0.31 | 1.29 ± 0.24 | 0.99 ± 0.21∗ |
| LDL (low density lipoprotein, mmol/L) | 2.29 ± 0.81 | 2.71 ± 0.53 | 3.09 ± 0.74∗ |
| TC (total cholesterol, mmol/L) | 5.29 ± 0.37 | 5.61 ± 0.21 | 5.78 ± 0.52 |
∗ P < 0.05 versus control group.